2-Oxazolidinone, 3-[[(5-nitro-2-furanyl)methylene]amino]- (BioDeep_00000175035)

Main id: BioDeep_00000001471

 

human metabolite blood metabolite


代谢物信息卡片


3-{[(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one

化学式: C8H7N3O5 (225.0386)
中文名称: 呋喃唑酮
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]
InChI: InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2

描述信息

G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones
C254 - Anti-Infective Agent

同义名列表

22 个代谢物同义名

3-{[(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one; 2-Oxazolidinone, 3-[[(5-nitro-2-furanyl)methylene]amino]-; 3-{[(5-nitro-2-furanyl)methylene]amino}-2-oxazolidinone; N-(5-Nitro-2-furfurylidene)-3-aminooxazolidine-2-one; 5-Nitro-N-(2-oxo-3-oxazolidinyl)-2-furanmethanimine; N-(5-Nitro-2-furfurylidene)-3-amino-2-oxazolidone; 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone; 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone; 3-[(5-Nitrofurylidene)amino]-2-oxazolidone; 3-(5-Nitrofurfuralamino)-2-oxazolidone; Nitrofurazolidonum; Nitrofurazolidone; Nifurazolidone; Furazolidonum; furazolidone; Furazolidona; Furazolidine; Furoxone; Furazol; FZL; Furazolidone; Furazolidone



数据库引用编号

14 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 9 AIMP2, CALR, CASP9, CAT, CCND1, CCND3, CDK6, CYP2C19, XDH
Peripheral membrane protein 1 AOC1
Endoplasmic reticulum membrane 6 CALR, CD4, CYP2C19, HMOX1, HSP90B1, TKT
Nucleus 9 AIMP2, CALR, CASP9, CCND1, CCND3, CDK6, HMOX1, HSP90B1, S100A8
cytosol 12 AIMP2, CALR, CASP9, CAT, CCND1, CCND3, CDK6, HMOX1, HSP90B1, S100A8, TKT, XDH
nuclear body 1 TKT
centrosome 3 CCND1, CCND3, CDK6
nucleoplasm 6 ATP2B1, CCND1, CCND3, CDK6, HMOX1, TKT
Cell membrane 5 AOC1, ATP2B1, CD4, JAG1, TKT
Cytoplasmic side 1 HMOX1
Multi-pass membrane protein 2 ATP2B1, ATP4A
Synapse 1 ATP2B1
cell surface 1 CALR
glutamatergic synapse 2 ATP2B1, CALR
postsynapse 1 CALR
presynaptic membrane 1 ATP2B1
smooth endoplasmic reticulum 2 CALR, HSP90B1
Cytoplasm, cytosol 2 AIMP2, CALR
acrosomal vesicle 1 CALR
plasma membrane 9 AOC1, ATP2B1, ATP4A, BCHE, CD4, CYP2C19, JAG1, S100A8, TKT
synaptic vesicle membrane 1 ATP2B1
Membrane 8 AIMP2, ATP2B1, ATP4A, CALR, CAT, HMOX1, HSP90B1, JAG1
apical plasma membrane 3 ATP4A, JAG1, TKT
basolateral plasma membrane 1 ATP2B1
extracellular exosome 7 AOC1, ATP2B1, CALR, CAT, HSP90B1, S100A8, TKT
endoplasmic reticulum 3 CALR, HMOX1, HSP90B1
extracellular space 8 AOC1, ATP4A, BCHE, CALR, GNRH1, HMOX1, S100A8, XDH
perinuclear region of cytoplasm 3 CALR, HMOX1, HSP90B1
adherens junction 1 JAG1
bicellular tight junction 2 AOC1, CCND1
mitochondrion 2 CASP9, CAT
protein-containing complex 3 CASP9, CAT, HSP90B1
intracellular membrane-bounded organelle 3 ATP2B1, CAT, CYP2C19
Single-pass type I membrane protein 3 CD4, JAG1, TKT
Secreted 1 BCHE
extracellular region 8 AOC1, BCHE, CALR, CAT, GNRH1, HSP90B1, JAG1, S100A8
mitochondrial outer membrane 1 HMOX1
mitochondrial matrix 1 CAT
Extracellular side 1 AOC1
Cytoplasm, cytoskeleton, microtubule organizing center, centrosome 1 CDK6
Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane 1 ATP2B1
Nucleus membrane 1 CCND1
nuclear membrane 1 CCND1
external side of plasma membrane 2 CALR, CD4
Secreted, extracellular space, extracellular matrix 1 CALR
actin cytoskeleton 1 TKT
midbody 1 HSP90B1
Early endosome 1 CD4
vesicle 1 TKT
Apical cell membrane 1 ATP4A
Membrane raft 1 CD4
focal adhesion 4 CALR, CAT, HSP90B1, TKT
Peroxisome 4 AOC1, CAT, TKT, XDH
sarcoplasmic reticulum 1 XDH
Peroxisome matrix 1 CAT
peroxisomal matrix 1 CAT
peroxisomal membrane 1 CAT
collagen-containing extracellular matrix 3 CALR, HSP90B1, S100A8
lateral plasma membrane 1 ATP2B1
ruffle 1 CDK6
receptor complex 1 TKT
cell projection 1 ATP2B1
phagocytic vesicle membrane 1 CALR
cytoskeleton 1 S100A8
Secreted, extracellular space 1 AOC1
blood microparticle 1 BCHE
Basolateral cell membrane 1 ATP2B1
nuclear envelope 1 CALR
Melanosome 1 HSP90B1
Presynaptic cell membrane 1 ATP2B1
sperm plasma membrane 1 HSP90B1
intermediate filament cytoskeleton 1 S100A8
ficolin-1-rich granule lumen 1 CAT
secretory granule lumen 2 CAT, S100A8
endoplasmic reticulum quality control compartment 1 CALR
endoplasmic reticulum lumen 4 BCHE, CALR, CD4, HSP90B1
transcription repressor complex 1 CCND1
specific granule lumen 1 AOC1
Endoplasmic reticulum-Golgi intermediate compartment membrane 1 CALR
immunological synapse 1 ATP2B1
Single-pass type IV membrane protein 1 HMOX1
nuclear envelope lumen 1 BCHE
apoptosome 1 CASP9
clathrin-coated endocytic vesicle membrane 1 CD4
Sarcoplasmic reticulum lumen 2 CALR, HSP90B1
lumenal side of endoplasmic reticulum membrane 1 CALR
MHC class I peptide loading complex 1 CALR
aminoacyl-tRNA synthetase multienzyme complex 1 AIMP2
cyclin-dependent protein kinase holoenzyme complex 3 CCND1, CCND3, CDK6
endocytic vesicle lumen 2 CALR, HSP90B1
ribosome 1 CALR
T cell receptor complex 1 CD4
catalase complex 1 CAT
calprotectin complex 1 S100A8
endoplasmic reticulum chaperone complex 1 HSP90B1
Cytoplasmic vesicle, secretory vesicle, Cortical granule 1 CALR
cortical granule 1 CALR
Cytolytic granule 1 CALR
photoreceptor ribbon synapse 1 ATP2B1
cyclin D1-CDK4 complex 1 CCND1
cyclin D3-CDK4 complex 1 CCND3
potassium:proton exchanging ATPase complex 1 ATP4A
cyclin D1-CDK6 complex 2 CCND1, CDK6
cyclin D3-CDK6 complex 2 CCND3, CDK6
caspase complex 1 CASP9
cyclin D2-CDK6 complex 1 CDK6


文献列表

  • Shengjuan Hu, Yan Zhou, Yanhong Deng, Yang Bo, Xianmei Chen, Wei Yang, Ruichun Shi, Wei Zhao, Zhanbing Hou, Jianping Hu, Jianguo Liu, Xilong Zhang, Heli Yong, Ping Wang, Fei Li, Hailong Qi, Xiaoyun Wang, Lijuan Jin, Ting Cui, Haijiang Yong, Xue Li, Bin Yang, Yuehua Yu, Bin Ma, Lei Fu, Xuemei Wang, Zhen Ma, Na Tang, Yanjie You, Jianyang Guo, Xiaobing Yu, Li Yao, Ruiping Gao, Yanling Li, Ruijuan Xin, Jianfang Liu, Zhenzi Cao, Hongliang Li, Linke Ma, Shoucheng Ma, Ying Cao, Yuanyuan Tang, Jun Liu, Qian Hao, Xiaofei Li, Xuemei Li, Rui Mu, Min Niu, Xiaoming Su, Hengjun Gao. Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia. Helicobacter. 2023 Jun; 28(3):e12960. doi: 10.1111/hel.12960. [PMID: 37042045]
  • Xueping Huang, Baihe Wu, Qiuzhao Chen, Yushan Chen, Xinhua Ji, Xiang Zhou, Biao Suo, Zhihui Lin, Xiaoling Zheng. Antibiotic resistance profile of Helicobacter pylori to 14 antibiotics: a multicenter study in Fujian, China. PeerJ. 2023; 11(?):e15611. doi: 10.7717/peerj.15611. [PMID: 37456872]
  • Selvarasu Maheshwaran, Ramachandran Balaji, Shen-Ming Chen, Yo-Shiuan Chang, Elayappan Tamilalagan, Narendhar Chandrasekar, Selvarajan Ethiraj, Melvin S Samuel, Mohanraj Kumar. Ultrasensitive electrochemical detection of furazolidone in biological samples using 1D-2D BiVO4@MoS2 hierarchical nano-heterojunction composites armed electrodes. Environmental research. 2022 04; 205(?):112515. doi: 10.1016/j.envres.2021.112515. [PMID: 34896319]
  • Qin Chen, Kelei Zhao, Heyue Li, Kanghua Liu, Jing Li, Yiwen Chu, Balakrishnan Prithiviraj, Bisong Yue, Xiuyue Zhang. Antibacterial and anti-virulence effects of furazolidone on Trueperella pyogenes and Pseudomonas aeruginosa. BMC veterinary research. 2022 Mar; 18(1):114. doi: 10.1186/s12917-022-03216-5. [PMID: 35331229]
  • Agata Zdarta, Wojciech Smułek, Zuzanna Bielan, Jakub Zdarta, Luong N Nguyen, Agnieszka Zgoła-Grześkowiak, Long D Nghiem, Teofil Jesionowski, Ewa Kaczorek. Significance of the presence of antibiotics on the microbial consortium in wastewater - The case of nitrofurantoin and furazolidone. Bioresource technology. 2021 Nov; 339(?):125577. doi: 10.1016/j.biortech.2021.125577. [PMID: 34304095]
  • Zhifeng Cai, Liangliang Wu, Kaifei Qi, Chenhua Deng, Caifeng Zhang. Blue-emitting glutathione-capped copper nanoclusters as fluorescent probes for the highly specific biosensing of furazolidone. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2021 Feb; 247(?):119145. doi: 10.1016/j.saa.2020.119145. [PMID: 33186816]
  • Xueping Huang, Yuan Liu, Zhihui Lin, Baihe Wu, Gaohui Nong, Yushan Chen, Yuping Lu, Xinhua Ji, Xiang Zhou, Biao Suo, Qiuzhao Chen, Jinqi Wei. Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China. PloS one. 2021; 16(9):e0256225. doi: 10.1371/journal.pone.0256225. [PMID: 34473713]
  • Jie Pan, Zhengchao Shi, Dingsai Lin, Ningmin Yang, Fei Meng, Lang Lin, Zhencheng Jin, Qingjie Zhou, Jiansheng Wu, Jianzhong Zhang, Youming Li. Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial. Frontiers of medicine. 2020 Feb; 14(1):43-50. doi: 10.1007/s11684-019-0706-8. [PMID: 31907860]
  • Dong-Min Yi, Tao-Tao Yang, Shuai-Heng Chao, Ya-Xin Li, Ying-Lei Zhou, Hai-Hui Zhang, Ling Lan, Yu-Wei Zhang, Xue-Mei Wang, Yan-Rui Zhang, Jian Li, Song-Ze Ding. Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label study. Medicine. 2019 Feb; 98(6):e14408. doi: 10.1097/md.0000000000014408. [PMID: 30732192]
  • Muhammad Avais, Ghazanfar Rashid, Muhammad Ijaz, Muhammad Arif Khan, Amar Nasir, Muhammad Shoaib Jahanzaib, Jawaria Ali Khan, Sajid Hameed, Michael Philipp Reichel. Evaluation of furazolidone, sulfadimidine and amprolium to treat coccidiosis in Beetal goats under field conditions. Pakistan journal of pharmaceutical sciences. 2016 Mar; 29(2):485-7. doi: . [PMID: 27087093]
  • Qin Yu, Weiyi Fang, Ning Zhu, Xiaoqun Zheng, Rongmei Na, Baiting Liu, Lili Meng, Zhu Li, Qianxiao Li, Xiaofei Li. Beneficial effects of intramyocardial mesenchymal stem cells and VEGF165 plasmid injection in rats with furazolidone induced dilated cardiomyopathy. Journal of cellular and molecular medicine. 2015 Aug; 19(8):1868-76. doi: 10.1111/jcmm.12558. [PMID: 25753859]
  • Helina Rahman, Manab Deka. Detection & characterization of necrotoxin producing Escherichia coli (NTEC) from patients with urinary tract infection (UTI). The Indian journal of medical research. 2014 Apr; 139(4):632-7. doi: NULL. [PMID: 24927352]
  • Tamalee Roberts, John Ellis, John Harkness, Deborah Marriott, Damien Stark. Treatment failure in patients with chronic Blastocystis infection. Journal of medical microbiology. 2014 Feb; 63(Pt 2):252-257. doi: 10.1099/jmm.0.065508-0. [PMID: 24243286]
  • Li-Feng Zhang, Tao-Tao Lu, Shu-Qiu Zhang, Wen-Han Lin, Qing-Shan Li. Pharmacokinetics and tissue distribution of furanodiene W/O/W multiple emulsions in rats by a fast and sensitive HPLC-APCI-MS/MS method. Xenobiotica; the fate of foreign compounds in biological systems. 2013 Dec; 43(12):1095-102. doi: 10.3109/00498254.2013.793434. [PMID: 23638824]
  • Yu Liu, Dapeng Peng, Lingli Huang, Yulian Wang, Chao Chang, Awais Ihsan, Yanfei Tao, Bo Yang, Zonghui Yuan. Application of a modified enzyme-linked immunosorbent assay for 3-amino-2-oxazolidinone residue in aquatic animals. Analytica chimica acta. 2010 Apr; 664(2):151-7. doi: 10.1016/j.aca.2010.02.010. [PMID: 20363397]
  • Lida Fotouhi, Sara Banafsheh, Majid M Heravi. Electrochemistry of the interaction of furazolidone and bovine serum albumin. Bioelectrochemistry (Amsterdam, Netherlands). 2009 Nov; 77(1):26-30. doi: 10.1016/j.bioelechem.2009.05.011. [PMID: 19643680]
  • H K Tiwari, Jully G Tiwari. Studies on the residues of terramycin and furazolidone in broiler meat--a public health concern. Indian journal of public health. 2008 Jan; 52(1):33-6. doi: NULL. [PMID: 18700719]
  • Xiao-Zhong Hu, Ying Xu, Ayfer Yediler. Determinations of residual furazolidone and its metabolite, 3-amino-2-oxazolidinone (AOZ), in fish feeds by HPLC-UV and LC-MS/MS, respectively. Journal of agricultural and food chemistry. 2007 Feb; 55(4):1144-9. doi: 10.1021/jf062902a. [PMID: 17300147]
  • Anakalo Shitandi, Aila Oketch, Symon Mahungu. Evaluation of a Bacillus stearothermophilus tube test as a screening tool for anticoccidial residues in poultry. Journal of veterinary science. 2006 Jun; 7(2):177-80. doi: 10.4142/jvs.2006.7.2.177. [PMID: 16645344]
  • K M Cooper, P P J Mulder, J A van Rhijn, L Kovacsics, R J McCracken, P B Young, D G Kennedy. Depletion of four nitrofuran antibiotics and their tissue-bound metabolites in porcine tissues and determination using LC-MS/MS and HPLC-UV. Food additives and contaminants. 2005 May; 22(5):406-14. doi: 10.1080/02652030512331385218. [PMID: 16019811]
  • L A Khan, S Jalali, S M H Andrabi, M A Mirza. Serum profiles of luteinizing hormone, oestradiol and cholesterol and ovarian functions in layer poultry birds (Gallus domesticus) fed diets containing furazolidone. Veterinary research communications. 2004 Apr; 28(3):247-59. doi: 10.1023/b:verc.0000017285.69075.66. [PMID: 15074770]
  • A Auro, H Sumano, L Ocampo, A Barragán. Evaluation of the carcinogenic effects of furazolidone and its metabolites in two fish species. The pharmacogenomics journal. 2004; 4(1):24-8. doi: 10.1038/sj.tpj.6500216. [PMID: 14647403]
  • Jiin-Ju Guo, Hong-Nong Chou, I Chiu Liao. Disposition of 3-(4-cyano-2-oxobutylidene amino)-2-oxazolidone, a cyano-metabolite of furazolidone, in furazolidone-treated grouper. Food additives and contaminants. 2003 Mar; 20(3):229-36. doi: 10.1080/0265203021000043930. [PMID: 12623646]
  • A M Timperio, H A Kuiper, L Zolla. Identification of a furazolidone metabolite responsible for the inhibition of amino oxidases. Xenobiotica; the fate of foreign compounds in biological systems. 2003 Feb; 33(2):153-67. doi: 10.1080/0049825021000038459. [PMID: 12623758]
  • S Dutta, K Rajendran, S Roy, A Chatterjee, P Dutta, G B Nair, S K Bhattacharya, S-I Yoshida. Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000. Epidemiology and infection. 2002 Oct; 129(2):235-43. doi: 10.1017/s0950268802007240. [PMID: 12403099]
  • J C Harris, S Plummer, D Lloyd. Antigiardial drugs. Applied microbiology and biotechnology. 2001 Dec; 57(5-6):614-9. doi: 10.1007/s002530100720. [PMID: 11778868]
  • S A Calafatti, R A Ortiz, M Deguer, M Martinez, J Pedrazzoli. Effect of acid secretion blockade by omeprazole on the relative bioavailability of orally administered furazolidone in healthy volunteers. British journal of clinical pharmacology. 2001 Aug; 52(2):205-9. doi: 10.1046/j.0306-5251.2001.01435.x. [PMID: 11488780]
  • T E Nash. Treatment of Giardia lamblia infections. The Pediatric infectious disease journal. 2001 Feb; 20(2):193-5. doi: 10.1097/00006454-200102000-00015. [PMID: 11224841]
  • J Szych, A Cieślik, J Paciorek, S Kałuzewski. [Multidrug resistance to antibacterial drugs of Salmonella enterica subsp. enterica strains isolated in Poland in the 1998-1999 period]. Medycyna doswiadczalna i mikrobiologia. 2001; 53(1):17-29. doi: . [PMID: 11757401]
  • T B Gardner, D R Hill. Treatment of giardiasis. Clinical microbiology reviews. 2001 Jan; 14(1):114-28. doi: 10.1128/cmr.14.1.114-128.2001. [PMID: 11148005]
  • A A Al-Qarawi, B H Ali, A G Abdel-Gayoum. Plasma and hepatic lipid profiles in furazolidone-treated rats. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie. 2000 Aug; 52(4):364-6. doi: 10.1016/s0940-2993(00)80064-0. [PMID: 10987192]
  • R J McCracken, M A McCoy, D G Kennedy. Furazolidone residues in pigs: criteria to distinguish between treatment and contamination. Food additives and contaminants. 2000 Jan; 17(1):75-82. doi: 10.1080/026520300283612. [PMID: 10793857]
  • S M Andrabi, M M Ahmad, M Shahab. Furazolidone treatment suppresses pubertal testosterone secretion in male broiler breeder birds (Gallus domesticus). Veterinary and human toxicology. 1998 Dec; 40(6):321-5. doi: NULL. [PMID: 9830689]
  • D Dionisio, L I Manneschi, S Di Lollo, A Orsi, G Sterrantino, F Leoncini, M Pozzi, M A Vinattieri, A Tani, A Papucci. Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients. Journal of clinical pathology. 1998 Oct; 51(10):731-6. doi: 10.1136/jcp.51.10.731. [PMID: 10023334]
  • A S Kumar. Serum level of furazolidone. Indian pediatrics. 1998 Sep; 35(9):923-7. doi: NULL. [PMID: 10216610]
  • P Dutta, U Mitra, R Rasaily, M R Saha, B Manna, M K Chatterjee, T Garai, M Sengupta, S K Bhattacharya. Multi-drug resistant typhoid fever with diarrhea. Indian pediatrics. 1997 Oct; 34(10):891-9. doi: NULL. [PMID: 9567551]
  • A S Kumar, M Legori. Minimum inhibitory concentration of furazolidone in children with typhoid fever. Indian pediatrics. 1997 Oct; 34(10):951-2. doi: NULL. [PMID: 9567566]
  • R J McCracken, D G Kennedy. The bioavailability of residues of the furazolidone metabolite 3-amino-2-oxazolidinone in porcine tissues and the effect of cooking upon residue concentrations. Food additives and contaminants. 1997 Jul; 14(5):507-13. doi: 10.1080/02652039709374558. [PMID: 9328536]
  • D Dionisio, L I Manneschi, S Di Lollo, A Orsi, G Sterrantino, M Meli, M Gabbrielli, A Tani, A Papucci, F Leoncini. Enterocytozoon bieneusi in AIDS: symptomatic relief and parasite changes after furazolidone. Journal of clinical pathology. 1997 Jun; 50(6):472-6. doi: 10.1136/jcp.50.6.472. [PMID: 9378811]
  • C C Cruz, L Ferrari, R Sogayar. [A therapeutic trial in Giardia muris infection in the mouse with metronidazole, tinidazole, secnidazole and furazolidone]. Revista da Sociedade Brasileira de Medicina Tropical. 1997 May; 30(3):223-8. doi: 10.1590/s0037-86821997000300009. [PMID: 9273569]
  • R J McCracken, M A McCoy, D G Kennedy. The prevalence and possible causes of bound and extractable residues of the furazolidone metabolite 3-amino-2-oxazolidinone in porcine tissues. Food additives and contaminants. 1997 Apr; 14(3):287-94. doi: 10.1080/02652039709374526. [PMID: 9135726]
  • F W Kari, R Weaver, M C Neville. Active transport of nitrofurantoin across the mammary epithelium in vivo. The Journal of pharmacology and experimental therapeutics. 1997 Feb; 280(2):664-8. doi: . [PMID: 9023277]
  • V A Zurabyan, N V Pavlovich, L N Makarovskaya, V V Ryzhkova, O K Bugaeva. [In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 1997; 42(11):22-5. doi: NULL. [PMID: 9463297]
  • K Yoshida, F Kondo. Liquid chromatographic determination of furazolidone in swine serum and avian egg. Journal of AOAC International. 1995 Jul; 78(4):1126-9. doi: 10.1093/jaoac/78.4.1126. [PMID: 7580327]
  • A S Kumar, M Legori, N Sathy, R Mathew. Furazolidone in typhoid fever--correlation of clinical efficacy with serum bactericidal activity. Indian pediatrics. 1995 May; 32(5):533-8. doi: NULL. [PMID: 8613310]
  • Q Zaman, M Z Khan, N Islam, G Muhammad. Experimental furazolidone toxicosis in broiler chicks: effect of dosage, duration and age upon clinical signs and some blood parameters. Acta veterinaria Hungarica. 1995; 43(2-3):359-67. doi: NULL. [PMID: 7491876]
  • S M Plakas, K R el Said, G R Stehly. Furazolidone disposition after intravascular and oral dosing in the channel catfish. Xenobiotica; the fate of foreign compounds in biological systems. 1994 Nov; 24(11):1095-105. doi: 10.3109/00498259409038669. [PMID: 7701851]
  • D M Queiroz, S B Moura, E N Mendes, G A Rocha, A J Barbosa, A S de Carvalho. Effect of Helicobacter pylori eradication on G-cell and D-cell density in children. Lancet (London, England). 1994 May; 343(8907):1191-3. doi: 10.1016/s0140-6736(94)92401-5. [PMID: 7909869]
  • D S Long, C M Li, Q G Yang. [Clinical observation on verrucous gastritis with combined therapy of traditional Chinese and Western medicine]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 1994 Mar; 14(3):150-1, 132. doi: ". [PMID: 7950183]
  • D Lax, R T Holman, S B Johnson, S L Zhang, Y Li, G R Noren, N A Staley, S Einzig. Myocardial lipid composition in turkeys with dilated cardiomyopathy. Cardiovascular research. 1994 Mar; 28(3):407-13. doi: 10.1093/cvr/28.3.407. [PMID: 8174162]
  • D M Queiroz, E N Mendes, G A Rocha, S B Moura, L M Resende, J R Cunha-Melo, L G Coelho, M C Passos, C A Oliveira, G F Lima Júnior. Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication. The American journal of gastroenterology. 1993 Aug; 88(8):1228-32. doi: NULL. [PMID: 8338090]
  • B Sas. Contribution to the pathobiochemistry of furazolidone-induced oxidative toxicity in chickens. Acta veterinaria Hungarica. 1993; 41(1-2):103-21. doi: . [PMID: 8116490]
  • P J O'Brien, M O'Grady, J H Lumsden, D L Holmberg, H Shen, J E Weiler, R D Horn, S M Mirsalimi, R J Julian. Clinical pathologic profiles of dogs and turkeys with congestive heart failure, either noninduced or induced by rapid ventricular pacing, and turkeys with furazolidone toxicosis. American journal of veterinary research. 1993 Jan; 54(1):60-8. doi: NULL. [PMID: 8427473]
  • L A Hoogenboom, M C Berghmans, T H Polman, R Parker, I C Shaw. Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side-chain from liver, kidney and muscle tissues from pigs. Food additives and contaminants. 1992 Nov; 9(6):623-30. doi: 10.1080/02652039209374117. [PMID: 1302201]
  • Z Rahim, A Ali, B A Kay, R Zeaur, A Akbar, A K Bradford. Prevalence of Plesiomonas shigelloides among diarrhoeal patients in Bangladesh. European journal of epidemiology. 1992 Sep; 8(5):753-6. doi: 10.1007/bf00145397. [PMID: 1296610]
  • B H Ali. Effect of furazolidone on tissue sulphydryl groups, ascorbic acid, and lipid peroxide levels in the rat, and the influence of dimethylsulphoxide thereon. Pharmacological research. 1992 Apr; 25(3):247-54. doi: 10.1016/s1043-6618(05)80073-8. [PMID: 1518768]
  • O B Samuelsen, E Solheim, B T Lunestad. Fate and microbiological effects of furazolidone in a marine aquaculture sediment. The Science of the total environment. 1991 Oct; 108(3):275-83. doi: 10.1016/0048-9697(91)90364-k. [PMID: 1754880]
  • D M Webb, D B DeNicola, J F Van Vleet. Serum chemistry alterations, including creatine kinase isoenzymes, in furazolidone toxicosis of ducklings: preliminary findings. Avian diseases. 1991 Oct; 35(4):662-7. doi: . [PMID: 1785996]
  • C M Czarnecki. Influence of exogenous T4 on body weight, feed consumption, T4 levels, and myocardial glycogen in furazolidone-fed turkey poults. Avian diseases. 1991 Oct; 35(4):930-6. doi: 10.2307/1591630. [PMID: 1786022]
  • A L Bartlet, S Harvey, H Klandorf. Contrasting effects of nitrofurans on plasma corticosterone in chickens following administration as a bolus or diet additive. Journal of veterinary pharmacology and therapeutics. 1990 Sep; 13(3):261-9. doi: 10.1111/j.1365-2885.1990.tb00775.x. [PMID: 2231866]
  • I Kassis, R Dagan, M Chipman, M Alkan, A Simo, R Gorodischer. The use of prophylactic furazolidone to control a nosocomial epidemic of multiply resistant Salmonella typhimurium in pediatric wards. The Pediatric infectious disease journal. 1990 Aug; 9(8):551-5. doi: 10.1097/00006454-199008000-00005. [PMID: 2235170]
  • A Rampling, R Upson, D F Brown. Nitrofurantoin resistance in isolates of Salmonella enteritidis phage type 4 from poultry and humans. The Journal of antimicrobial chemotherapy. 1990 Feb; 25(2):285-90. doi: 10.1093/jac/25.2.285. [PMID: 2184161]
  • M S Arbid, M M el-Habbak, M S Hanafy. Toxicological and biological studies on Japanese quails fed graded levels of furazolidone. Acta veterinaria Hungarica. 1990; 38(4):271-9. doi: . [PMID: 2099613]
  • J F Nouws, J Laurensen. Postmortal degradation of furazolidone and furaltadone in edible tissues of calves. The veterinary quarterly. 1990 Jan; 12(1):56-9. doi: 10.1080/01652176.1990.9694243. [PMID: 2321352]
  • L L Gromashevskaia, A D Vovk, V S Neborachko, M G Kasatkina, E Iu Kudriashova. [Excretion of bile acids in feces in pathology of the liver and intestines]. Laboratornoe delo. 1990; ?(12):25-9. doi: NULL. [PMID: 1710688]
  • E Szabóová, J Dányi. [Use of urinary furazolidone determination in calves in laboratory diagnosis]. Veterinarni medicina. 1989 Nov; 34(11):651-8. doi: NULL. [PMID: 2609476]
  • B M Zhang, X R Song. [Comparative study of the effect of wei-yan-ning and furazolidone in the treatment of gastritis and gastric ulcer caused by pyloric Campylobacter]. Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine. 1989 Oct; 9(10):599-600, 581. doi: . [PMID: 2605737]
  • G H Rabbani, M R Islam, T Butler, M Shahrier, K Alam. Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial. Antimicrobial agents and chemotherapy. 1989 Sep; 33(9):1447-50. doi: 10.1128/aac.33.9.1447. [PMID: 2684006]
  • T McCallum, S F Badylak, J F Van Vleet, W M Reed. Furazolidone-induced injury in the isolated perfused chicken heart. American journal of veterinary research. 1989 Jul; 50(7):1183-5. doi: NULL. [PMID: 2774341]
  • A Valadez-Salazar, H Guiscafre-Gallardo, S Sanchez-Garcia, O Muñoz. Detection of furazolidone in human biological fluids by high performance liquid chromatography. The Journal of antimicrobial chemotherapy. 1989 Apr; 23(4):589-95. doi: 10.1093/jac/23.4.589. [PMID: 2745262]
  • W E Stroo, S W Schaffer. Furazolidone-enhanced production of free radicals by avian cardiac and hepatic microsomal membranes. Toxicology and applied pharmacology. 1989 Mar; 98(1):81-6. doi: 10.1016/0041-008x(89)90136-1. [PMID: 2538946]
  • A H White. Absorption, distribution, metabolism, and excretion of furazolidone. A review of the literature. Scandinavian journal of gastroenterology. Supplement. 1989; 169(?):4-10. doi: 10.3109/00365528909091325. [PMID: 2694342]
  • W E Stroo. A comparison of furazolidone and doxorubicin enhanced free radical chemistry. Research communications in chemical pathology and pharmacology. 1988 Dec; 62(3):435-46. doi: ". [PMID: 2851864]
  • D Lax, S L Zhang, Y Li, L Williams, J M Berry, J Elsperger, N A Staley, G R Noren, S Einzig. Reduced lipid peroxidation in dilated hearts of cardiomyopathic turkeys. Cardiovascular research. 1988 Nov; 22(11):826-32. doi: 10.1093/cvr/22.11.826. [PMID: 3256424]
  • P Hekman, E C Rietveld. The absorption of a new sustained release furazolidone formulation from the digestive tract of piglets and calves. The veterinary quarterly. 1988 Oct; 10(4):265-9. doi: 10.1080/01652176.1988.9694183. [PMID: 3218069]
  • B H Ali, J L Silsby, K J Loseth, B Crabo, M E el Halawani. Some effects of furazolidone on the testis and plasma levels of testosterone, luteinizing hormone and prolactin in mature male turkeys. International journal of andrology. 1988 Apr; 11(2):141-52. doi: 10.1111/j.1365-2605.1988.tb00990.x. [PMID: 3372046]
  • B H Ali, J L Silsby, F Edens, M E el Halawani. Effects of furazolidone or nitrofurazone on the concentrations of hypothalamic amines and plasma luteinizing hormone (LH) and prolactin (PRL), levels in young turkeys. General pharmacology. 1988; 19(1):91-5. doi: 10.1016/0306-3623(88)90011-0. [PMID: 3126094]
  • A J Streeter, T R Krueger, B A Hoener. Oxidative metabolites of 5-nitrofurans. Pharmacology. 1988; 36(4):283-8. doi: 10.1159/000138396. [PMID: 3380882]
  • B H Ali, J Silsby, M E el Halawani. Effect of furazolidone and nitrofurazone on egg production, on plasma luteinising hormone and on prolactin concentrations in turkeys. British poultry science. 1987 Dec; 28(4):613-21. doi: 10.1080/00071668708416997. [PMID: 3446332]
  • L H Vroomen, M C Berghmans, P Hekman, L A Hoogenboom, H A Kuiper. The elimination of furazolidone and its open-chain cyano-derivative from adult swine. Xenobiotica; the fate of foreign compounds in biological systems. 1987 Dec; 17(12):1427-35. doi: 10.3109/00498258709044003. [PMID: 3326298]
  • G Hunder, A Schmid, L Mayring. Investigation on the metabolic degradation of the side chain of furazolidone. Archives of toxicology. 1987 Dec; 61(2):161-3. doi: 10.1007/bf00661377. [PMID: 3439890]
  • A Morales, P Richter, M I Toral. Polarographic determination of nitrofurazone and furazolidone in pharmaceutical formulations and urine. The Analyst. 1987 Jul; 112(7):971-3. doi: 10.1039/an9871200971. [PMID: 3619069]
  • M K Minev, S Iordanov, D Ganovski, V Khvŭrchilkov, I Veselinova. [Epizootiology, prevention and control of salmonellosis in swine]. Veterinarno-meditsinski nauki. 1987; 24(6):52-60. doi: NULL. [PMID: 3672906]
  • A I Mustafa, B H Ali, T Hassan. The effect of furazolidone on some clinical and biochemical parameters in goats. The veterinary quarterly. 1986 Oct; 8(4):295-300. doi: 10.1080/01652176.1986.9694058. [PMID: 3798711]
  • L H Vroomen, M C Berghmans, T D van der Struijs. Determination of furazolidone in swine plasma, muscle, liver, kidney, fat and urine based on high-performance liquid chromatographic separation after solid-phase extraction on Extrelut 1. Journal of chromatography. 1986 Jul; 362(1):141-5. doi: 10.1016/s0021-9673(01)86962-4. [PMID: 3745362]
  • G Kasper, N Dickgiesser. [Clinical significance, epidemiology and laboratory diagnosis of Campylobacter pyloridis]. Immunitat und Infektion. 1986 Apr; 14(2):58-62. doi: NULL. [PMID: 3710514]
  • T Hassan, A M Homeida, B H Ali. Effects of furazolidone on some reproductive hormones during oestrous cycle in the goat. Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology. 1986; 85(2):255-7. doi: 10.1016/0742-8413(86)90191-x. [PMID: 2879685]
  • C M Czarnecki. Changes in myocardial ultrastructure during development of furazolidone-induced cardiomyopathy in turkeys. Journal of comparative pathology. 1986 Jan; 96(1):77-88. doi: 10.1016/0021-9975(86)90024-1. [PMID: 3944289]
  • C E Kirkpatrick, J P Laczak. Giardiasis in a cattery. Journal of the American Veterinary Medical Association. 1985 Jul; 187(2):161-2. doi: NULL. [PMID: 4030450]
  • A I MacIntosh, G Lauriault, G A Neville. Liquid chromatographic monitoring of the depletion of carbadox and its metabolite desoxycarbadox in swine tissues. Journal - Association of Official Analytical Chemists. 1985 Jul; 68(4):665-71. doi: NULL. [PMID: 4030637]
  • D P Stevens. Selective primary health care: strategies for control of disease in the developing world. XIX. Giardiasis. Reviews of infectious diseases. 1985 Jul; 7(4):530-5. doi: 10.1093/clinids/7.4.530. [PMID: 3898310]
  • A I Mustafa, B H Ali, T Hassan, A M Satti. Furazolidone concentrations in plasma, milk and some tissues of Nubian goats. Journal of veterinary pharmacology and therapeutics. 1985 Jun; 8(2):190-3. doi: 10.1111/j.1365-2885.1985.tb00943.x. [PMID: 4020949]
  • M E Pierpont, D Judd, B Borgwardt, G R Noren, N A Staley, S Einzig. Carnitine alterations in spontaneous and drug-induced turkey congestive cardiomyopathy. Pediatric research. 1985 May; 19(5):415-20. doi: 10.1203/00006450-198505000-00001. [PMID: 4000766]
  • L K Pickering. Problems in diagnosing and managing giardiasis. Pediatric infectious disease. 1985 May; 4(3 Suppl):S6-10. doi: NULL. [PMID: 2409542]
  • A S Shi. [Advances in clinical observations and experimental research on peptic ulcer treated with traditional Chinese medicine and western medicine]. Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine. 1985 Jan; 5(1):59-62. doi: ". [PMID: 3156686]
  • V Nitzulescu, V Balotă, A Morfei. [New alternative in treating cestodiasis and in particular hymenolepiasis due to Hymenolepis nana]. Revista de pediatrie, obstetrica si ginecologie. Pediatria. 1985 Jan; 34(1):77-82. doi: NULL. [PMID: 3925534]
  • A I Mustafa, B H Ali, A M Satti. HPLC analysis of furazolidone in goats given the therapeutic dose. Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology. 1985; 81(1):167-9. doi: 10.1016/0742-8413(85)90109-4. [PMID: 2861044]
  • B H Ali, A Khogali. Plasma and histological changes in furazolidone treated chickens. Research in veterinary science. 1984 Nov; 37(3):290-2. doi: . [PMID: 6522822]
  • C E Kirkpatrick, J P Farrell. Feline giardiasis: observations on natural and induced infections. American journal of veterinary research. 1984 Oct; 45(10):2182-8. doi: NULL. [PMID: 6497121]